Organ-on-a-chip: current gaps and future directions

Author:

Candarlioglu Pelin L.1ORCID,Dal Negro Gianni1,Hughes David2,Balkwill Frances3,Harris Kate4,Screen Hazel5,Morgan Hywel6,David Rhiannon7,Beken Sonja8,Guenat Olivier9,Rowan Wendy10,Amour Augustin11ORCID

Affiliation:

1. In Vitro/In Vivo Translation-Complex In Vitro Models, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.

2. CN Bio Innovations Ltd, Cambridge, U.K.

3. Barts Cancer Institute, Queen Mary University of London, London, U.K.

4. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, U.K.

5. School of Engineering and Material Science, Queen Mary University of London, London, U.K.

6. Electronics and Computer Science, University of Southampton, Southampton, U.K.

7. Safety Innovation, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, U.K.

8. Federal Agency for Medicines and Health Products, Brussels, Belgium

9. ARTORG Center, University of Bern, Bern, Switzerland

10. Novel Human Genetics Research Unit GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.

11. Immunology Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.

Abstract

As an emerging hot topic of the last decade, Organ on Chip (OoC) is a new technology that is attracting interest from both basic and translational scientists. The Biochemical Society, with its mission of supporting the advancement of science, with addressing grand challenges that have societal impact, has included OoC into their agenda to review the current state of the art, bottlenecks and future directions. This conference brought together representatives of the main stakeholders in the OoC field including academics, end-users, regulators and technology developers to discuss and identify requirements for this new technology to deliver on par with the expectations and the key challenges and gaps that still need to be addressed to achieve robust human-relevant tools, able to positively impact decision making in the pharmaceutical industry and reduce overreliance on poorly predictive animal models.

Publisher

Portland Press Ltd.

Subject

Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3